A recent study published in the Journal of Psychopharmacology examined the effectiveness of psychedelic-assisted therapy on ...

Patients with non-seasonal depression who were treated with bright light therapy reported a 40% remission rate, according to a recent study.

Dr John R. Kelly writes how easing regulatory constraints would facilitate the advance of the scientific evidence ...

Bright light therapy was associated with improved treatment response and remission rates among patients with nonseasonal depression.

A new study published in the journal Psychedelics found that psilocybin therapy can help in the treatment of people with an ...

Psychedelic-assisted therapy is a combined method that uses psychotherapy and pharmacotherapy with the help of psychedelics ...

Researchers have found that a device delivering direct brain stimulation, known as transcranial direct current stimulation ...

Psilocybin therapy -- used to treat a range of mental health conditions, such as depression, anxiety, and addictions -- can ...

Treatment for Mixed Anxiety-Depressive Disorder typically involves a combination of psychotherapy and, in some cases, medication. Here are the most common therapeutic approaches: Cognitive-Behavioural ...

With one in five young people suffering from a mental health issue, Dr Miriam Stoppard reveals the new digital support ...

Seasonal Affective Disorder is characterized by symptoms similar to major depressive disorder, including low energy, changes ...

Detailed price information for Intra-Cellular Ther (ITCI-Q) from The Globe and Mail including charting and trades.